152 related articles for article (PubMed ID: 37210494)
21. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
[TBL] [Abstract][Full Text] [Related]
22. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
23. [Study on expressions of CD25 and CD127 in CD4+ peripheral T lymphocytes of patients with rheumatoid arthritis].
Huang ZX; Zheng BR; Li TW; Lu YM; Gu JR; Han XY
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2476-80. PubMed ID: 20137434
[TBL] [Abstract][Full Text] [Related]
24. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
[TBL] [Abstract][Full Text] [Related]
25. Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.
Baraut J; Grigore EI; Jean-Louis F; Khelifa SH; Durand C; Verrecchia F; Farge D; Michel L
Bone Marrow Transplant; 2014 Mar; 49(3):349-54. PubMed ID: 24362364
[TBL] [Abstract][Full Text] [Related]
26. [Effects of ulinastatin on immune function of spleen in severely burned rats and its mechanism].
Li J; Hu C; Yao Y; Yang H
Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):266-71. PubMed ID: 27188484
[TBL] [Abstract][Full Text] [Related]
27. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
29. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
[TBL] [Abstract][Full Text] [Related]
30. Increased frequency of CD4+CD25(high)FoxP3+ regulatory T cells in patients with hepatocellular carcinoma.
Feng X; Li B; Ye H; Long D
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):309-14. PubMed ID: 21633918
[TBL] [Abstract][Full Text] [Related]
31. [Changes of CD4+CD25+ regulatory T cells, IL-10 and TGF-beta1 levels in peripheral blood in children with asthma].
Li M; Song L; Zhang JB; Fang J; Li L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):829-32. PubMed ID: 19849943
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo expansion of antigen-specific CD4+CD25+ regulatory T cells from autologous naïve CD4+ T cells of multiple sclerosis patients as a potential therapeutic approach.
Xiang YJ; Ren M; Jiang H; Yang TT; He Y; Ao DH; Wang YY; Zhang Q; He XJ; Gao XG; Liu GZ
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5261-5270. PubMed ID: 28051239
[TBL] [Abstract][Full Text] [Related]
33. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
Fahim NM; Monir E
Egypt J Immunol; 2006; 13(1):173-87. PubMed ID: 17974160
[TBL] [Abstract][Full Text] [Related]
34. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
35. [Inhibition of CD4+ CD25+ regulatory T cells in chronic hepatitis B patients].
Zhang HH; Guo F; Fei R; Ma H; Cong X; Wei L; Chen HS
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):511-5. PubMed ID: 18649763
[TBL] [Abstract][Full Text] [Related]
36. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
37. CD127(low/-) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood.
Klein S; Kretz CC; Krammer PH; Kuhn A
J Invest Dermatol; 2010 Feb; 130(2):492-9. PubMed ID: 19940860
[TBL] [Abstract][Full Text] [Related]
38. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
39. T-regulatory lymphocytes in peripheral blood of gastric and colorectal cancer patients.
Szczepanik AM; Siedlar M; Sierzega M; Goroszeniuk D; Bukowska-Strakova K; Czupryna A; Kulig J
World J Gastroenterol; 2011 Jan; 17(3):343-8. PubMed ID: 21253393
[TBL] [Abstract][Full Text] [Related]
40. Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species.
Rodriguez-Pinto D; Navas A; Blanco VM; Ramírez L; Garcerant D; Cruz A; Craft N; Saravia NG
PLoS Negl Trop Dis; 2012; 6(4):e1627. PubMed ID: 22545172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
